JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB233300

APC/Cy7® Anti-CD8 antibody [MEM-31]

Be the first to review this product! Submit a review

|

(2 Publications)

Mouse Monoclonal CD8 alpha antibody - conjugated to APC/Cy7®. Suitable for Flow Cyt and reacts with Human samples. Cited in 2 publications. Immunogen corresponding to Tissue preparation containing CD8A protein.

View Alternative Names

CD8a, MAL, CD8A, T-cell surface glycoprotein CD8 alpha chain, T-lymphocyte differentiation antigen T8/Leu-2

2 Images
Flow Cytometry - APC/Cy7® Anti-CD8 antibody [MEM-31] (AB233300)
  • Flow Cyt

Supplier Data

Flow Cytometry - APC/Cy7® Anti-CD8 antibody [MEM-31] (AB233300)

Separation of human CD8 positive lymphocytes (red-filled) from neutrophil granulocytes (black-dashed) in flow cytometry analysis (surface staining) of human peripheral whole blood stained using anti-human CD8 (MEM-31) APC-Cy™7 antibody (4 µl reagent / 100 µl of peripheral whole blood).

Flow Cytometry - APC/Cy7® Anti-CD8 antibody [MEM-31] (AB233300)
  • Flow Cyt

Supplier Data

Flow Cytometry - APC/Cy7® Anti-CD8 antibody [MEM-31] (AB233300)

Flow cytometry surface staining pattern of human peripheral whole blood stained using anti-human CD8 (MEM-31) APC-Cy™7 antibody (4 µl reagent / 100 µl of peripheral whole blood).

Key facts

Host species

Mouse

Clonality

Monoclonal

Clone number

MEM-31

Isotype

IgG2a

Conjugation

APC/Cy7®

Excitation/Emission

Ex: 650nm, Em: 785nm

Carrier free

No

Reacts with

Human

Applications

Flow Cyt

applications

Immunogen

Tissue preparation containing CD8A protein. The exact immunogen used to generate this antibody is proprietary information.

P01732

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "FlowCyt-species-checked": "testedAndGuaranteed", "FlowCyt-species-dilution-info": "4 µL for 10^6 Cells", "FlowCyt-species-notes": "<p>(or 100 μL whole blood)</p>" } } }

Product details

This product or portions thereof is manufactured under license from Carnegie Mellon University under U.S. Patent Number 5, 268, 486 and related patents. Cy® and CyDye® are trademarks of Cytiva.

Properties and storage information

Form
Liquid
Purification technique
Size-exclusion chromatography
Purification notes
The purified antibody is conjugated with tandem dye APC-Cy™7 under optimum conditions. The conjugate is purified by size-exclusion chromatography and adjusted for direct use. No reconstitution is necessary.
Storage buffer
pH: 7.4 Preservative: 0.0975% Sodium azide Constituents: PBS
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Storage information
Store in the dark

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

CD8 also known as CD8a or Leu-2 is a glycoprotein with a molecular weight of approximately 32 kDa. It is prominently expressed on the surface of cytotoxic T lymphocytes. These CD8 molecules facilitate the interaction between T cells and antigen-presenting cells by binding to major histocompatibility complex (MHC) class I molecules. This interaction is essential for the immune system to recognize and destroy infected or cancerous cells. CD8 is often identified using various markers like CD8 FITC CD8 APC and CD8 PerCP which are used in flow cytometry for cell sorting and analysis.
Biological function summary

CD8 plays a significant role in the adaptive immune response. It is not part of a multimeric complex but functions as a co-receptor that enhances the recognition of antigens by the T cell receptor (TCR). The presence of CD8 molecules aids the activation of T cells leading to their proliferation and the effective targeting and elimination of pathogens or abnormal cells. The ability of CD8 to bind to MHC class I molecules allows cytotoxic T cells to detect and respond to nearly all nucleated cells in the body.

Pathways

CD8 is integral in both the T cell receptor signaling pathway and the induction of apoptosis. In the T cell receptor signaling pathway CD8 works closely with other proteins like Lck and ZAP-70 to transmit signals upon TCR-MHC class I engagement. This promotes T cell activation cytokine production and cell division. Furthermore CD8's interaction with Fas ligand pathways contributes to the initiation of programmed cell death which is important for maintaining immune homeostasis and preventing overreaction of the immune system.

CD8 T cells are significant in the context of viral infections and autoimmune diseases. For example during HIV infection the depletion of CD8 T cells impairs the immune response allowing the virus to evade the immune system. Additionally in autoimmune disorders like Type 1 diabetes CD8 T cells mistakenly target and destroy insulin-producing beta cells in the pancreas. These pathological processes also involve proteins such as MHC class I and other immune modulators like interleukins that modulate CD8 T cell activity and differentiation.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

The protein expressed by the gene CD8A is an integral membrane glycoprotein crucial for immune responses, operating mainly in T-cells as a coreceptor for MHC class I molecule : peptide complexes. These peptides originate from cytosolic proteins, unlike class II peptides, which are from extracellular proteins. CD8A interacts with the T-cell receptor (TCR) and MHC class I proteins on antigen-presenting cells, recruiting the Src kinase LCK to the TCR-CD3 complex. LCK phosphorylates substrates, triggering signaling pathways that lead to the production of lymphokines, enhanced motility, adhesion, and activation of cytotoxic T-lymphocytes (CTLs), thereby aiding in the recognition and elimination of infected or tumor cells. Additionally, in natural killer (NK) cells, CD8A homodimers on the cell surface provide a survival mechanism for conjugating with and lysing multiple target cells. CD8A homodimers also facilitate the survival and differentiation of activated lymphocytes into memory CD8 T-cells. This supplementary information is collated from multiple sources and compiled automatically.
See full target information CD8A

Publications (2)

Recent publications for all applications. Explore the full list and refine your search

BMC infectious diseases 24:229 PubMed38378486

2024

Chlamydia trachomatis enhances HPV persistence through immune modulation.

Applications

Unspecified application

Species

Unspecified reactive species

Yingying Lu,Qi Wu,Li Wang,Lingting Ji

Immunity, inflammation and disease 10:e723 PubMed36301026

2022

Low serum level of 25-OH vitamin D relates to Th17 and treg changes in colorectal cancer patients.

Applications

Unspecified application

Species

Unspecified reactive species

Bai Chen,Liugen Jin
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com